Senseonics has revealed promising results for its Eversense technology, a long-term implantable continuous glucose monitoring (CGM) system. The PRECISE II trial looked at the safety and ...

GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company's ...

Glucotrack (Nasdaq:GCTK) may be bringing its continuous blood glucose monitor (CBGM) technology to automated insulin delivery ...

We are working in conjunction with Dr. Jacob Segil of CU Boulder and Dr. Richard Weir of CU Anschutz on an implantable glucose fuel cell for medical uses. Our team is interested in developing ...

1 The researchers speculated that when combined with a smartphone application, the technology could help patients with diabetes continuously and noninvasively monitor their blood glucose levels. Many ...

Glucose Sensor MarketThe global glucose sensor market is projected to witness substantial growth, reaching a valuation of USD 20,421.4 million by 2034, according to a recent report. The market, ...

The Glucotrack Continuous Blood Glucose Monitor is a long-term implantable device for continuous blood glucose monitoring without external components. When will Glucotrack present its trial data?

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient ...

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...